THYROID CANCER

This study tests a combination of two drugs, anlotinib and benmelstobart, as a second treatment option for people with advanced thyroid cancer that has spread or cannot be removed by surgery. About 23 adults whose cancer did not respond to or worsened after initial therapy will r…

This study compares two surgical approaches for people with early-stage thyroid cancer located in the isthmus (the bridge of the thyroid). One group will have only the tumor and nearby lymph nodes removed, while the other group will have the entire thyroid removed. The goal is to…

This early-phase trial tests a new radioactive drug (177Lu-INN805) in 10 adults with advanced solid tumors like head & neck, thyroid, lung, breast, or sarcoma cancer who have not responded to standard treatments. The drug is given every 6 weeks for up to 4 cycles to find the safe…

This study looks at people with high-risk thyroid cancer who need radioactive iodine treatment. After stopping their thyroid hormones to prepare for treatment, they will receive either the standard replacement or a short course of two hormones together. The goal is to see which a…

This early-stage trial tests a radioactive drug (177Lu-DOTA-EB-TATE) in 18 adults with a rare, aggressive thyroid cancer (Hurthle cell) that has spread and no longer responds to standard radioactive iodine. The drug targets a protein found in high numbers on these cancer cells. T…

This study tests whether a short video can help people who receive radioiodine treatment for thyroid cancer or hyperthyroidism. After treatment, patients must follow safety steps and may have side effects that feel stressful. The video explains these in a simple, reassuring way. …

This study tests a therapy called Meaning-Centered Psychotherapy for Latinos (MCP-L) to see if it helps reduce anxiety and depression and improve quality of life in 300 Mexican patients with advanced breast, prostate, colorectal, or thyroid cancer. Participants will be randomly a…

This study aims to improve how doctors predict and monitor thyroid cancer by combining tumor genetics with proteins found in urine. Researchers will follow 100 newly diagnosed thyroid cancer patients to see if these markers can detect cancer recurrence earlier than current method…

This study is for young adults (ages 21-45) who had certain cancers as teens or young adults. Researchers are adapting a program that helps patients manage follow-up care and feel more in control of their health. The goal is to see if the program is helpful and practical for use …